Cited by 31Medical Imaging Techniques and ApplicationsLymphoma Diagnosis and TreatmentLung Cancer Diagnosis and Treatment

The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations

Open access
Ly, John, Minarik, David, Edenbrandt, Lars, Wollmer, Per, Trägårdh, Elin·2019·EJNMMI Research

Abstract

The Deauville score (DS) is a clinical tool, based on the comparison between lesion and reference organ uptake of 18 F-fluorodeoxyglucose (FDG), used to stratify patients with lymphoma into categories reflecting their disease status. With a plethora of positron emission tomography with computed tomography (PET-CT) hard- and software algorithms, standard uptake value (SUV) in lesions and reference organs may differ which affects DS classification and therefore medical treatment. The EANM Research Ltd. (EARL) harmonization program from the European Association of Nuclear Medicine (EANM) partly mitigates this issue, but local preferences are common in clinical practice. We have investigated the discordance in DS calculated from patients with lymphoma referred for 18 F-FDG PET-CT reconstructed with three different algorithms: the newly introduced block-sequential regularization expectation-maximization algorithm commercially sold as Q. Clear (QC, GE Healthcare, Milwaukee, WI, USA), compliant with the newly proposed updated EARL recommendations, and two settings compliant with the current EARL recommendations (EARL lower and EARL upper , representing the lower and upper limit of the EARL recommendations). Fifty-two patients with non-Hodgkin and Hodgkin lymphoma were included (18 females and 34 males). Segmentation of mediastinal blood pool and liver were semi-automatically performed, whereas segmentation of lesions was done manually. From these segmentations, SUV max and SUV peak were obtained and DS calculated. There was a significant difference in DS between the QC algorithm and EARL lower /EARL upper ( p < 0.0001 for both) but not between EARL lower and EARL upper ( p = 0.102) when SUV max was used. For SUV peak , there was a significant difference between QC and EARL lower ( p = 0.001), but not for QC vs EARL upper ( p = 0.071) or EARL lower vs EARL upper ( p = 0.102). Five non-responders (DS 4–5) for QC were classified as responders (DS 1–3) when EARL lower /EARL upper was used, both when SUV max and SUV peak were investigated. Using the proposed updated EARL recommendations compared with the current recommendations will significantly change DS classification. In select cases, the discordance would affect the choice of medical treatment. Specifically, the current EARL recommendations were more often prone to classify patients as responders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13550-019-0536-3

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a study on 52 patients with lymphoma, 5 patients undergoing [18F]FDG-PET for restaging were divergently classified as non-responders (Deauville score 4-5) with PL reconstruction but as responders (Deauville 1-3) with OSEM.

    “In a study on 52 patients with lymphoma, 5 patients undergoing [18F]FDG-PET for restaging were divergently classified as non-responders (Deauville score 4–5) with PL reconstruction but as responders (Deauville 1–3) with OSEM (without TOF or PSF; compliant with the EARL1 standard) [176].”

    From Influences on PET Quantification and Interpretation (2022) · cites this paper as [176]

    The Results (Patients and Quantitative analysis; pages unavailable) report 52 patients and five QC non-responders (Deauville 4–5) classified as responders (Deauville 2–3) with EARL reconstruction. The Methods (PET-CT acquisition and reconstruction parameters; page unavailable) identify QC as Q.Clear and the EARL reconstructions as OSEM without resolution recovery or time of flight. The study included baseline, interim, end-of-treatment and suspected-recurrence scans; it does not identify all five reclassified patients as undergoing restaging. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Both SUV measurements and visual Deauville criteria may be affected by image reconstruction, such as PL reconstruction.

    “However, both SUV measurements and visual Deauville criteria may be affected by image reconstruction, such as PL reconstruction [176].”

    From Influences on PET Quantification and Interpretation (2022) · cites this paper as [176]

    The Methods (PET-CT acquisition and reconstruction parameters; Image analysis) compare different reconstruction algorithms and calculate Deauville scores from SUVmax and SUVpeak. The Results (Quantitative analysis) show that those scores can differ by reconstruction. The paper does not assess visually assigned Deauville criteria, so that part of the claim is not established. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ly, J., Minarik, D., Edenbrandt, L., Wollmer, P., & Trägårdh, E.
Affiliations
  • Lund University (SE)
  • Sahlgrenska University Hospital (SE)
Corresponding author
Ly, John
Venue
EJNMMI Research
Published
2019-07-25
Volume
9
Issue
1
Pages
65-65
ISSN
2191-219X (ISSN-L)
OpenAlex
W2963708288
Cited by
31
References
15
Citations by year
2026: 3 · 2024: 1 · 2023: 6 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 2
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • EJNMMI Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • Knut och Alice Wallenbergs Stiftelse
  • Skåne County Council's Research and Development Foundation
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
Deauville score, 18F-FDG PET/CT, non-Hodgkin lymphoma, Hodgkin's disease, Q.Clear, standardized uptake value, SUVmax, SUVpeak, treatment response classification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review